Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
NCT07080970 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2025-07-23
Summary
This is a multicenter observational study with a retrospective and a prospective cohort investigating clinically and biologically the APL-like subset as a potential predictor of coagulopathy and susceptibility to early vascular events.
Conditions
- Acute Myeloid Leukemia
- NPM1 Mutation
Interventions
- OTHER
-
observation of incidence of early vascular events
observation of difference incidence of early vascular events in the two cohorts
Sponsors & Collaborators
-
Gruppo Italiano Malattie EMatologiche dell'Adulto
lead OTHER
Principal Investigators
-
Francesco Mannelli · SOD Ematologia, Università di Firenze, AOU Careggi
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-30
- Primary Completion
- 2027-12-31
- Completion
- 2028-11-30
More Related Trials
-
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
NCT04460950 ·Status: RECRUITING
-
Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine
NCT03588078 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
NCT02756962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
NCT04589728 ·Status: COMPLETED
-
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
NCT02714790 ·Status: COMPLETED
-
Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
NCT07023588 ·Status: RECRUITING ·Phase: PHASE2
-
AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment
NCT07203885 ·Status: COMPLETED ·Phase: NA
-
Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database
NCT02309333 ·Status: TERMINATED
-
A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
NCT02200978 ·Status: COMPLETED ·Phase: PHASE4
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING
-
Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
NCT00962767 ·Status: COMPLETED ·Phase: PHASE3
-
CD155 Expression in Acute Myeloid Leukemia
NCT06369662 ·Status: COMPLETED
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate
NCT02067143 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Values of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia Patients With Allo-HSCT
NCT03715621 ·Status: UNKNOWN
-
Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia
NCT07036809 ·Status: COMPLETED
-
A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia
NCT00400673 ·Status: COMPLETED ·Phase: PHASE2
-
Home or Away From Home - Descriptive Interviews (Aim 2)
NCT02794207 ·Status: COMPLETED
-
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
NCT01570465 ·Status: TERMINATED
-
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review
NCT03047083 ·Status: COMPLETED
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
NCT02875093 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
NCT03072043 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
NCT02084563 ·Status: COMPLETED ·Phase: PHASE2